EGFR and cancer: The mechanism of its anti-cancer activity has been elucidated by metastasis inhibition, a block of the cell cycle at the G2/M phase, and apoptosis induction, which are commonly known to be disrupted by the epidermal growth factor receptor (EGFR) signaling pathways [7,8].